Q32 Bio Ownership | Who Owns Q32 Bio?


OverviewForecastFinancialsChart

Q32 Bio Ownership Summary


Q32 Bio is owned by 73.59% institutional investors, 6.57% insiders, and 19.85% retail investors. Orbimed advisors is the largest institutional shareholder, holding 18.47% of QTTB shares.

QTTB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockQ32 Bio73.59%6.57%19.85%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors2.25M18.47%$3.36M
Atlas venture life science advisors2.09M17.15%$3.12M
Carlyle group1.10M9.04%$1.62M
Monaco asset management sam591.94K4.85%$881.99K
Arch venture management320.48K2.63%$477.52K
Pfizer277.78K2.28%$413.89K
Sanofi244.08K2.00%$363.68K
Blackrock funding, inc. /de178.68K1.46%$266.23K
Acadian asset management29.74K0.24%$44.00K
Affinity asset advisors27.78K0.23%$41.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atlas venture life science advisors2.09M0.47%$3.12M
Sanofi244.08K0.21%$363.68K
Arch venture management320.48K0.16%$477.52K
Monaco asset management sam591.94K0.15%$881.99K
Orbimed advisors2.25M0.08%$3.36M
Pfizer277.78K0.07%$413.89K
Carlyle group1.10M0.03%$1.62M
Affinity asset advisors27.78K0.01%$41.39K
Eversource wealth advisors5.30K0.00%$7.90K
Srs capital advisors1.11K0.00%$1.66K

Top Buyers

HolderShares% AssetsChange
Monaco asset management sam591.94K0.15%86.49K
Marshall wace, llp16.93K-16.93K
Eversource wealth advisors5.30K0.00%5.21K
Srs capital advisors1.11K0.00%1.11K
Mirae asset global investments471.00-63.00

Top Sellers

HolderShares% AssetsChange
Sio capital management---697.41K
Temasek (private)---313.94K
Blackrock funding, inc. /de178.68K--278.69K
Arrowmark colorado---81.48K
Mariner11.78K--73.00K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp16.93K-16.93K$25.22K
Srs capital advisors1.11K0.00%1.11K$1.66K

Sold Out

HolderChange
Thompson investment management-4.00
Farther finance advisors-6.00
Bfsg-11.00
Jones financial companies lllp-16.00
Nisa investment advisors-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202558-15.94%8,975,90322.91%732.05%22-12.00%19-5.00%
Mar 31, 202570-25.53%9,406,755-13.54%770.95%26-57.38%20122.22%
Dec 31, 20249533.80%10,995,64120.72%911.60%6240.91%912.50%
Sep 30, 20247129.09%9,108,41312.93%751.66%4425.71%814.29%
Jun 30, 20245541.03%8,065,3288.55%670.13%35-7.89%7-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 26, 2025Morrison Jodie Pope CEOSell$18.90K
Aug 26, 2025Violette Shelia M. Chief Scientific OfficerSell$5.38K
Aug 26, 2025Kalowski Lee CFO and PresidentSell$7.64K
Mar 25, 2024TZIANABOS ARTHUR-Sell$6.41K
Mar 25, 2024Alloway Paul See RemarksSell$6.49K

Insider Transactions Trends


DateBuySell
2025 Q3-3
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

QTTB Ownership FAQ


Who Owns Q32 Bio?

Q32 Bio shareholders are primarily institutional investors at 73.59%, followed by 6.57% insiders and 19.84% retail investors. The average institutional ownership in Q32 Bio's industry, Biotech Stocks , is 306.59%, which Q32 Bio falls below.

Who owns the most shares of Q32 Bio?

Q32 Bio’s largest shareholders are Orbimed advisors (2.25M shares, 18.47%), Atlas venture life science advisors (2.09M shares, 17.15%), and Carlyle group (1.1M shares, 9.04%). Together, they hold 44.66% of Q32 Bio’s total shares outstanding.

Does Blackrock own Q32 Bio?

BlackRock is not among the top 10 institutional shareholders of Q32 Bio.

Who is Q32 Bio’s biggest shareholder by percentage of total assets invested?

Atlas venture life science advisors is Q32 Bio’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 2.09M Q32 Bio shares, valued at 3.12M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools